Blackwell Kimberly

Director at ZNTL

Sold, on record
$324k
Dollars the filings state
Form 4 sales
4
Latest Jan 3, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ZNTLZentalis Pharmaceuticals, Inc.Director

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ZNTLPlan not stated
    Oct 25, 2021 2021

    Sold 1,000 shares at $77.59 ($78k)

    Blackwell Kimberly, Director

    Sold 16.7% of holdings ($466k position)5,000 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ZNTLPlan not stated
    Nov 1, 2021 +7 days

    Sold 1,000 shares at $80.46 ($80k)

    Blackwell Kimberly, Director

    Sold 16.7% of holdings ($483k position)5,000 shares leftFiling

  3. 3 Form 4 sale ZNTLPlan not stated
    Dec 1, 2021 +30 days

    Sold 1,000 shares at $81.84 ($82k)

    Blackwell Kimberly, Director

    Sold 16.7% of holdings ($491k position)5,000 shares leftFiling

  4. 4 Form 4 sale ZNTLPlan not stated
    Jan 3, 2022 +33 days

    Sold 1,000 shares at $83.74 ($84k)

    Blackwell Kimberly, Director

    Sold 16.7% of holdings ($502k position)5,000 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Blackwell Kimberly
Source
Jan 3, 2022Jan 5, 2022ZNTLDirectorForm 4 sale1,000$84k16.7%Plan not statedSEC
Dec 1, 2021Dec 2, 2021ZNTLDirectorForm 4 sale1,000$82k16.7%Plan not statedSEC
Nov 1, 2021Nov 2, 2021ZNTLDirectorForm 4 sale1,000$80k16.7%Plan not statedSEC
Oct 25, 2021Oct 27, 2021ZNTLDirectorForm 4 sale1,000$78k16.7%Plan not statedSEC